These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11514109)

  • 1. Menopause, hormone replacement therapy and cancer.
    La Vecchia C; Brinton LA; McTiernan A
    Maturitas; 2001 Aug; 39(2):97-115. PubMed ID: 11514109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk in menopausal women.
    La Vecchia C; Brinton LA; McTiernan A
    Best Pract Res Clin Obstet Gynaecol; 2002 Jun; 16(3):293-307. PubMed ID: 12099664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
    Pike MC; Ross RK
    Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous steroids for menopausal symptoms and breast/endometrial cancer risk.
    Mourits MJ; DE Bock GH
    Int J Gynecol Cancer; 2006; 16 Suppl 2():494-6. PubMed ID: 17010054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adverse effects of hormone replacement therapy.
    Tavani A; La Vecchia C
    Drugs Aging; 1999 May; 14(5):347-57. PubMed ID: 10408735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
    Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
    Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.
    Bakken K; Alsaker E; Eggen AE; Lund E
    Int J Cancer; 2004 Oct; 112(1):130-4. PubMed ID: 15305384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement.
    Persson I; Weiderpass E; Bergkvist L; Bergström R; Schairer C
    Cancer Causes Control; 1999 Aug; 10(4):253-60. PubMed ID: 10482483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HRT, breast and endometrial cancers: strategies and intervention options.
    Sismondi P; Biglia N; Giai M; Ponzone R; Roagna R; Sgro L; Campagnoli C
    Maturitas; 1999 Aug; 32(3):131-9. PubMed ID: 10515669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk in women receiving estrogen-progestin replacement therapy.
    Persson I
    Maturitas; 1996 May; 23 Suppl():S37-45. PubMed ID: 8865138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and cancer: an update.
    La Vecchia C; Franceschi S
    Eur J Cancer Prev; 2003 Feb; 12(1):3-4. PubMed ID: 12548104
    [No Abstract]   [Full Text] [Related]  

  • 19. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.